Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Risk factors of progressive community-acquired pneumonia in hospitalized children: a prospective study.

Huang CY, Chang L, Liu CC, Huang YC, Chang LY, Huang YC, Chiu NC, Lin HC, Ho YH, Chi H, Huang LM; Taiwan Pediatric Infectious Disease Alliance.

J Microbiol Immunol Infect. 2015 Feb;48(1):36-42. doi: 10.1016/j.jmii.2013.06.009. Epub 2013 Aug 28.

2.

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH Jr.

Pediatrics. 2004 Apr;113(4):701-7.

PMID:
15060215
3.

Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan.

Chen CJ, Lin PY, Tsai MH, Huang CG, Tsao KC, Wong KS, Chang LY, Chiu CH, Lin TY, Huang YC.

Pediatr Infect Dis J. 2012 Nov;31(11):e196-201. doi: 10.1097/INF.0b013e31826eb5a7.

PMID:
22935863
4.

Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.

Breuer O, Blich O, Cohen-Cymberknoh M, Averbuch D, Kharasch S, Shoseyov D, Kerem E.

Pediatr Pulmonol. 2015 May;50(5):495-502. doi: 10.1002/ppul.23159. Epub 2015 Feb 4.

PMID:
25652187
5.

Antibiotic treatment schemes for very severe community-acquired pneumonia in children: a randomized clinical study.

Ribeiro CF, Ferrari GF, Fioretto JR.

Rev Panam Salud Publica. 2011 Jun;29(6):444-50.

6.

Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia.

Myers AL, Hall M, Williams DJ, Auger K, Tieder JS, Statile A, Jerardi K, McClain L, Shah SS.

Pediatr Infect Dis J. 2013 Jul;32(7):736-40. doi: 10.1097/INF.0b013e318290bf63.

7.

Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia.

Tapısız A, Özdemir H, Çiftçi E, Belet N, Ince E, Doğru Ü.

J Infect Chemother. 2011 Aug;17(4):504-9. doi: 10.1007/s10156-011-0208-3. Epub 2011 Jan 22.

PMID:
21258955
8.

Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome.

Tsai MH, Huang YC, Chen CJ, Lin PY, Chang LY, Chiu CH, Tsao KC, Huang CG, Lin TY.

J Microbiol Immunol Infect. 2005 Apr;38(2):117-22.

PMID:
15843856
9.

Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.

Lui G, Ip M, Lee N, Rainer TH, Man SY, Cockram CS, Antonio GE, Ng MH, Chan MH, Chau SS, Mak P, Chan PK, Ahuja AT, Sung JJ, Hui DS.

Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5.

PMID:
19818051
10.

A cross-sectional study of the clinical characteristics of hospitalized children with community-acquired pneumonia in eight eastern cities in China.

Wang XF, Liu JP, Shen KL, Ma R, Cui ZZ, Deng L, Shang YX, Zhao DY, Wang LB, Wan LY, Sun YQ, Li YN, Jiang ZY, Xu H, Li XM, Wu ZQ, Liu ZL, Hu YH, Huang Y, He CH, Zhang H, Jiang YH, Liu H, Wang Z.

BMC Complement Altern Med. 2013 Dec 23;13:367. doi: 10.1186/1472-6882-13-367.

11.

[Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].

Wang Z, Zhang X, Wu J, Zhang W, Kuang H, Li X, Xuan W, Wang K, Ma L.

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Nov;37(11):824-30. Chinese.

PMID:
25604112
12.

Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.

Kaplan SL, Patterson L, Edwards KM, Azimi PH, Bradley JS, Blumer JL, Tan TQ, Lobeck FG, Anderson DC; Linezolid Pediatric Pheumonia Study Group. Pharmacia and Upjohn.

Pediatr Infect Dis J. 2001 May;20(5):488-94.

PMID:
11368105
13.
14.

Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children.

Lin CJ, Chen PY, Huang FL, Lee T, Chi CS, Lin CY.

J Microbiol Immunol Infect. 2006 Dec;39(6):489-95.

PMID:
17164952
15.

Community-acquired pneumonia in children.

Sinaniotis CA, Sinaniotis AC.

Curr Opin Pulm Med. 2005 May;11(3):218-25. Review.

PMID:
15818183
16.

[Etiology of community acquired pneumonia in inpatients children. Uruguay 1998-2004].

Ferrari C AM, Pirez G MC, Martínez A A, Algorta R G, Chamorro V F, Guala B MJ, Zabala Ch C, Giachetto L G, Montano L A.

Rev Chilena Infectol. 2007 Feb;24(1):40-7. Epub 2007 Mar 8. Spanish.

17.
18.

Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.

Lauderdale TL, Chang FY, Ben RJ, Yin HC, Ni YH, Tsai JW, Cheng SH, Wang JT, Liu YC, Cheng YW, Chen ST, Fung CP, Chuang YC, Cheng HP, Lu DC, Liu CJ, Huang IW, Hung CL, Hsiao CF, Ho M.

Respir Med. 2005 Sep;99(9):1079-86. Epub 2005 Apr 18.

19.

Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia.

Cohen JF, Leis A, Lecarpentier T, Raymond J, Gendrel D, Chalumeau M.

PLoS One. 2012;7(5):e36927. doi: 10.1371/journal.pone.0036927. Epub 2012 May 17.

20.

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine.

Ann Intern Med. 2009 Jan 6;150(1):19-26.

PMID:
19124816
Items per page

Supplemental Content

Write to the Help Desk